Phase III study to evaluate patient's preference of subcutaneous versus intravenous trastuzumab in HER2-positive metastatic breast cancer patients: Results from the ChangHER study (GEICAM/2012-07)
| Image |  |
|---|---|
| Description | scientific article published on 23 June 2020 |
| Author/s |
author: Eva M Ciruelos |
| Publication date | June 23, 2020 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |